Advisor, Biotech
E2MCCheck size: $250K-$2M initial investments, as published by E2MC.
Carolina Alarco is listed in a Advisor, Biotech capacity at E2MC. The firm does not publish a person-specific investment thesis for this role; this profile preserves that role distinction and uses the firm's mandate only as shared context.
Technically credible founders applying space capabilities or markets to large commercial opportunities on Earth and beyond.
The firm requires a meaningful space angle and excludes U.S.-adversary jurisdictions; companies without space relevance or beyond seed are outside the stated core.
Show the space angle, technical proof, commercial customer, regulatory path, global market and the milestone a $250K-$2M investment funds.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Carolina Alarco is a current Advisor, Biotech at E2MC, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.